XYWAV

Jazz Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Apr 25, 2023
Approval ID: 1e0ae43a-037f-42af-8e23-a0e51d75abe8
Products: 1 registered
Version: 12

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use XYWAV safely and effectively. See full prescribing information for XYWAV. XYWAV (calcium, magnesium, potassium, and sodium oxybates) oral solution, CIIIInitial U.S. Approval: 2002

Quick Stats

Total Products1

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.